Patent applications published 6 January 2010
Fusion proteins with cleavable spacers and use thereof. University of Southern California, 2139318
- Fusion proteins with cleavable spacers and use thereof
University of Southern California 2139318* - Method and compsns related to riboswitches that control alternative splicing
Yale University 2139319* - Methods and compsns of derivatives of probucol for the treatment of diabetes
Salutria Pharmaceuticals 2139320* - Lipoic acid derivatives
Cornerstone Pharmaceuticals 2139321* - Indole carboxamides as IKK2 inhibitors
SmithKline Beecham 2139322* - Treatment of Gaucher disease with specific pharmaceutical chaperones and monitoring treatment using surrogate markers
Amicus Therapeutics 2139323* - Anti-angiogenic agents and methods of use
Southern Research Institute 2139325* - Method for treating CB2 receptor mediated pain
Janssen Pharmaceutica 2139326* - Method for treating CB2 receptor mediated pain
Janssen Pharmaceutica 2139327* - Hexahydro-cycloheptapyrazole cannabinoid modulators
Janssen Pharmaceutica 2139328* - Novel imidazo based heterocycles
Abbott Laboratories 2139329* - Methods involving aldose reductase inhibitors
The Board of Regents of the University of Texas System 2139330* - Compsns and methods relating to novel compounds and targets thereof
The Regents of the University of Michigan 2139331* - Substituted pyrido[2,3-D]pyrimidine derivatives as cannabinoid-1 receptor modulators
Merck 2139332* - Substituted pyrido[3,2-E]triazolo[4,3-C]pyrimidine derivatives as cannabinoid-1 receptor modulators
Merck 2139333*
- 2-cyanophenyl fused heterocyclic compounds, and compsns and uses thereof
Renovis 2139334* - inhibitors of fibroblast activation protein, and methods of use thereof
Trustees of Tufts College 2139337* - Compsn and methods for cell killing
Oplon 2139338* - Compsns for nasal delivery
Yissum Research Development Company of the Hebrew University of Jerusalem 2139449*
- Membrane shell of an implantable dosage system
Bayer Schering Pharma Oy 2139450* - Topical compsns containing magaldrat
Difass 2139451* - Polyaphron topical compsn with vitamin Dand corticosteroid
Drug Delivery Solutions 2139452* - Polyaphron topical compsn with vitamin D
Drug Delivery Solutions 2139453* - Non-ionisable hydrophobic galenical system
Oralance Pharma 2139454*
- A tablet having improved stability with at least two actives
Reckitt Benckiser Healthcare (UK) 2139455* - Pharmaceutical compsn comprising candesartan cliexetil and method for manufacturing thereof
Zaklady Farmaceutyczne Polpharma. 2139456* - A drug delivery device for providing local analgesia, local anaesthesia or nerve blockage
Innocol Technologies 2139457* - A biodegradable microsphere compsn suitable for the controlled release of glucose containing peptide and formulation thereof
Dong-A Pharmaceutical 2139458* - Dermatological compsn for the prevention and/or treatment of rosacea, of couperose or of skin which exhibits diffuse redness or small dilated vessels
Pierre Fabre Dermo-Cosmetique 2139459* - Compsns and methods for the diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related neurological diseases
Brandeis University 2139460* - Amino derivatives to prevent nephrotoxicity and cancer
Recepticon Aps 2139461* - Calcimimetic compounds for use in the treatment of bowel disorders
Amgen; Geibel, John; Hebert, Steven 2139462* - Anti-infective agents
Technische Universitaet Carolo-Wilhelmini zu Braunschweig; KULeuven Research and Development 2139463*
- Anti-diabetic combinations comprising a slow release biguanide compsn and an immediate release dipeptidyl peptidase IVinhibitors compsn
Nectid 2139464* - Compsn comprising S-allyl-mercapto-N-acetylcysteine (ASSNAC) for up-regulation of cellular glutathione level
Ramot at Tel Aviv University; Yeda Research and Development Company 2139465* - Magnesium compsns and uses thereof
Liu, Guosong; Mesiter, Bernhard; Zhou, Hang 2139466* - Neuroprotection in demyelinating diseases
Gold, Ralf 2139467* - Hexahydro-cyclooctyl pyrazole cannabinoid modulators
Janssen Pharmaceutica 2139468* - Cobalamin taxane bioconjugates
Infabloc Pharmaceuticals 2139469* - Gamma radiation sterilised nanoparticulate docetaxel compsns and methods for making the same
Elan Pharma International 2139470* - Treatment of age-related macular degeneration using inhibitors of complement factor D
Alcon Research 2139471* - Tetrahydroindole derivatives as NADPHoxidase inhibitors
Genkto Tex 2139472* - Valsartan tablet formulations
Alembic 2139473* - Transcription factor modulating compounds and methods of use thereof
Paratek Pharmaceuticals 2139474* - The use of PDE7 inhibitors for the treatment of movement disorders
Omeros Corp 2139477* - Administration of carboline derivatives useful in the treatment of cancer and other diseases
PTCTherapeutics 2139476* - Pyrazolo pyridine derivatives as NADPHoxidase inhibitors
Genkto Tex 2139477* - Certain chemical entities, compsns and methods
Cytokinetics 2139478* - 4-[2-(4-methylphenylsulphanyl)-phenyl]-piperadine with combined serotonin and norepinephrine reuptake inhibition for the treatment of ADHD, melancholia, treatment resistant depression or residual symptoms in depression
H Lundbeck 2139479* - Ranolazine for enhancing insulin secretion
CVTherapeutics 2139480* - 1-[(2"-substituted)-piperazin-1"-yl]-isoquinolines as norepinephrine transporter inhibtor therapeutics and positron emission tomography imaging agents
The University of Montana 2139481* - Treatment for multiple myeloma
Ares Trading 2139482* - Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer
Exelixis 2139483* - Methods of treating cancer using pyridopyrimidinone inhibitors of P13K
alpha
Exelixis 2139484* - Methods of administering tetrahydrobiopterin, associated compsns and methods of measuring
BioMarin Pharmaceutical 2139485* - Combination of a purine-based CDKinhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
Cyclacel 2139486* - Inhibition of Bruton's tyrosine kinase
Pharmacyclics 2139487* - Use of riboflavin in the treatment of hypertension
University of Ulster; Western Health and Social Care Trust, Altnagelvin Hospital 2139488*
- Mineralocorticoid receptor modulators
Merck 2139489* - Diazolo bicyclic SMACmimetics and the uses thereof
The Regents of the University of Michigan 2139490* - Use of glucocorticoids for treatment of congestive heart failure
Durect Corp 2139491* - Methods for treating neovascular ocular diseases
Fovea Pharmaceuticals; Combinatorx 2139492* - Compsns containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells or the organism
Codex 2139493* - Pharmaceutical formulations containing dapaglifozin propylene glycol hydrate
Bristol-Myers Squibb 2139494* - Oligonucleotide compsns for the treatment of Alzheimer's disease
VIBVZW 2139496* - Methods of treating nervous system injury and disease
Stemnion 2139497* - Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NKcell activity
Dendreon 2139498* - Recombinant vitamin Kdependent proteins with high salic acid content and methods of preparing same
Inspiration Biopharmaceuticals 2139499* - Device which enhances the biological activity of locally applied growth factors with particular emphasis on those used for bone repair
University of Southern California 2139500* - Use of Francisella tularensis for prevention and treatment of allergic airway disorders
National Research Council of Canada 2139501* - Probiotics for use in reducing eosinophilia and respiratory allergies
Danisco 2139502* - Standardised bioactive herbal extracts
Ranbaxy Laboratories 2139504* - Novel pharmaceutical compsn for use as a laxative
Madaus 2139505* - Compsn comprising rehmanniae radix preparata, notoginseng radix or mixture extract thereof for preventing and treating of periodontitis as an effective component
Oscotec 2139506* - Methods and compsns for fostering and preserving bone growth
Unigene Laboratories 2139507* - Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
Genentech 2139508* - Treatment of autoimmune disorders
Biogen Idec 2139509* - Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly
Academia Sinica 2139510* - Pharmaceutical compsn comprising a cytokine
4SC 2139511* - Ischaemic disorder or disease inhibitors
Pronas Pharma 2139512*